Pharmacologic Inhibition of FGFR Modulates the Metastatic Immune Microenvironment and Promotes Response to Immune Checkpoint Blockade

Overview of attention for article published in Cancer Immunology Research, December 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Readers on

mendeley: 31 Mendeley

So far, Altmetric has seen 8 X posts from 5 X users, with an upper bound of 6,589 followers.

RT @CIR_AACR: Sequential dosing of an #FGFR inhibitor followed by #ImmuneCheckpointBlockade limits #metastatic tumor growth and increases o…

Sequential dosing of an #FGFR inhibitor followed by #ImmuneCheckpointBlockade limits #metastatic tumor growth and increases overall survival. Learn more: @xtremophile @PUCancerCenter @DrugDiscoveryPU @wendtlab_cancer #Immunotherapy #BreastCancer #FIIN4…

RT @WendtLab_cancer: Congrats to @xtremophile on publication of his work about the influence of FGFR inhibition on #Immunotherapy in #metas…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.